Global Etanercept Market, By Drug Type (Enbrel, Benepali Other), Application (Juvenile Idiopathic Arthritis (JIA), Ankylosing Spondylitis, Rheumatoid Arthritis, Psoriatic Arthritis, Others), Dosage (Injection, Solution, Others), Route of Administration (Subcutaneous, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), Country (U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa) Industry Trends and Forecast to 2028.
Market Analysis and Insights: Global Etanercept Market
Global etanercept market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the market to account to USD 22.36 million by 2028 growing at a CAGR of 3.7% in the above mentioned forecast period.
Etanercept is an injectable drug which is used for the treatment of autoimmune diseases such as rheumatoid arthritis, spondylitis, plaque and psoriatic arthritis. It is a protein based therapy which is based on the binding fragment of tumour necrosis factor alpha receptor. It is sold under the brand name of Enbrel.
Increase in the incidence of lifestyle disorders such as hypertension, diabetes, accidents, obesityand rise in the prevalence ofspondylitis will enhance the etanercept market growth. Furthermore growing demand of enbrel and rise in usage of the product for the treatment of autoimmune diseases such as rheumatoid arthritis and plaque are the factors that will expand the global etanercept market.
Rise in research and development activities and technological advancement will provide beneficial opportunities for the global etanercept market in the forecast period of 2021-2028.
High cost of treatment and lack of reimbursement policies are the factors that will hinder the market growth and will further challenge the global etanercept market in the forecast period mentioned above.
This etanercept market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the etanercept market contact Data Bridge Market Research for anAnalyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Etanercept Market Scope and Market Size
The etanercept market is segmented on the basis of drug type, application, dosage, route of administration and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- On the basis of drug type, the etanercept market is segmented into enbrel, benepali and others.
- On the basis of application, the etanercept market is segmented intojuvenile idiopathic arthritis (JIA), ankylosing spondylitis, rheumatoid arthritis, psoriatic arthritis and others.
- On the basis of dosage, the etanercept market is segmented into injection, solution and others.
- On the basis of route of administration, the etanercept market is segmented into subcutaneous and others.
The etanercept market is also segmented on the basis of distribution channel into hospital pharmacy, retail pharmacy and online pharmacy.
Etanercept Market Country Level Analysis
Etanercept market is analysed and market size information is provided by the country, drug type, application, dosage, route of administration and distribution channel as referenced above.
The countries covered in the etanercept market report are the U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa.
North America dominates the etanercept market due to the presence of well-developed healthcare sector, favourable reimbursement scenario and technological advancement in this region. Asia-Pacific is expected to grow during the forecast period 2021 to 2028 due to the major key players, increasing research and development activities, collaboration of biotech and pharmaceutical companies with research institutes.
The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.
Patient Epidemiology Analysis
Global etanercept market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.
Competitive Landscape and Global Etanercept Market Share Analysis
Etanercept market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to etanercept market.
The major players covered in the etanercept market report are GlaxoSmithKline plc, Novartis AG,F. Hoffmann-La Roche Ltd., Pfizer Inc., Cipla Inc., CELLTRION INC., Samsung Bioepis, and Takeda Pharmaceutical Company Limited., among other domestic and global players. Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
SKU-